Making Sense of Immunotherapy in Lung Cancer: What the Pulmonologist Needs to Know? Article

Santos, Edgardo S, Turquie, Moises Harari, Castillero, Lilibeth et al. (2018). Making Sense of Immunotherapy in Lung Cancer: What the Pulmonologist Needs to Know? . 7(2), 42-48. 10.1007/s13665-018-0200-9

cited authors

  • Santos, Edgardo S; Turquie, Moises Harari; Castillero, Lilibeth; Raez, Luis E; Rolfo, Christian

authors

publication date

  • June 1, 2018

webpage

keywords

  • ATEZOLIZUMAB
  • CHEMOTHERAPY
  • Checkpoint inhibitor
  • DISEASE
  • DOCETAXEL
  • Immunotherapy
  • Interstitial lung disease
  • Life Sciences & Biomedicine
  • Lung cancer
  • MANAGEMENT
  • MULTICENTER
  • NIVOLUMAB
  • OPEN-LABEL
  • PEMBROLIZUMAB
  • Pneumonitis
  • Pulmonary toxicity
  • Respiratory System
  • Science & Technology
  • THERAPY

Digital Object Identifier (DOI)

publisher

  • SPRINGER

start page

  • 42

end page

  • 48

volume

  • 7

issue

  • 2